Braak Stage, Cerebral Amyloid Angiopathy, and Cognitive Decline in Early Alzheimer’s Disease

As a paid scientific consultant for Green Valley Pharmaceutical, LLC which has a drug, GV-971, for treating Alzheimer's disease. The drug was recently conditionally approved for patient's use (per prescription by doctors) within China, and a global clinical trial is being planned to start 2020

Consulting fees from Signant Health